Trial intelligence / Profile preview

IV Amantadine for Gait Freezing in Parkinson's Disease

NCT01313845Phase 4Completed

Start
Feb 2011
Primary completion
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amantadine hydrochloride intravenous solution in Parkinson's disease (PD). Started Feb 2011; status: completed.

02

Drugs

amantadine hydrochloride intravenous solution
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT01313845.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01313845.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call